Longevity Medicine, Functional Wellness & Anti-Aging Insights from HormoneSynergy®

The term “Type 3 Diabetes” has been used to describe patterns of insulin resistance in the brain. While not an official diagnosis, it reflects a growing understanding of how metabolic health may influence cognitive function over time.

Insulin resistance is a foundational driver of metabolic dysfunction that may also influence brain health over time. Understanding this connection is key to protecting long-term cognitive function and overall longevity.

Fasting insulin is one of the earliest indicators of metabolic dysfunction—and it may also play a role in long-term brain health. Even when glucose appears normal, elevated insulin can signal underlying risk.

Lp(a) is a genetic cardiovascular risk marker often missed in routine labs. Learn why elevated lipoprotein(a) matters for longevity and preventive cardiology.

The idea that Alzheimer’s is “Type 3 diabetes” has gained traction—but it’s not the full story. Here’s what’s true, what’s oversimplified, and how this fits into a longevity medicine perspective.

A recent large observational study suggests statins may be associated with lower Alzheimer’s risk, but the full story is more complex. Here’s what the data actually shows, what it does not prove, and how it fits into a longevity medicine perspective.

ApoB reflects the number of atherogenic particles in circulation. Understanding optimal ranges helps clarify cardiovascular risk beyond traditional cholesterol measurements.

Lp(a) levels are genetically determined, but knowing what is considered high can help clarify cardiovascular risk. Understanding Lp(a) thresholds is key to interpreting this often-overlooked marker.

ApoB and LDL-P both estimate atherogenic particle burden, but they are not identical. Understanding how they differ helps clarify cardiovascular risk beyond standard cholesterol panels.

LDL-C and LDL-P are related, but they are not the same. In some people, LDL cholesterol appears normal while LDL particle number remains elevated, creating a discordance that can underestimate cardiovascular risk.

“Anti-aging” may sound appealing, but it is often more marketing than medicine. At HormoneSynergy®, we believe in a more honest approach: longevity medicine focused on preventing, slowing, and sometimes helping reverse the common diseases and patterns associated with aging through earlier, more thoughtful care.

LDL particle number (LDL-P) provides a deeper look at cardiovascular risk by measuring the number of LDL particles, not just the cholesterol they carry. It can reveal hidden risk even when LDL-C appears normal.